132 related articles for article (PubMed ID: 20473999)
1. Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts.
Burke JP; Watson RW; Mulsow JJ; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2010 Jun; 97(6):892-901. PubMed ID: 20473999
[TBL] [Abstract][Full Text] [Related]
2. Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts.
Burke JP; Cunningham MF; Watson RW; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2010 Jul; 97(7):1126-34. PubMed ID: 20632282
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts.
Burke JP; Watson RW; Murphy M; Docherty NG; Coffey JC; O'Connell PR
Br J Surg; 2009 May; 96(5):541-51. PubMed ID: 19358180
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
[TBL] [Abstract][Full Text] [Related]
5. N-cadherin is overexpressed in Crohn's stricture fibroblasts and promotes intestinal fibroblast migration.
Burke JP; Cunningham MF; Sweeney C; Docherty NG; O'Connell PR
Inflamm Bowel Dis; 2011 Aug; 17(8):1665-73. PubMed ID: 21287659
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.
Mulsow JJ; Watson RW; Fitzpatrick JM; O'Connell PR
Ann Surg; 2005 Dec; 242(6):880-7, discussion 887-9. PubMed ID: 16327498
[TBL] [Abstract][Full Text] [Related]
7. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
8. Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/2 MAPK activation.
Rodríguez-Barbero A; Obreo J; Alvarez-Munoz P; Pandiella A; Bernabéu C; López-Novoa JM
Cell Physiol Biochem; 2006; 18(1-3):135-42. PubMed ID: 16914898
[TBL] [Abstract][Full Text] [Related]
9. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.
Cunningham MF; Docherty NG; Burke JP; O'Connell PR
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G457-66. PubMed ID: 20489045
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
11. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts.
Obreo J; Díez-Marques L; Lamas S; Düwell A; Eleno N; Bernabéu C; Pandiella A; López-Novoa JM; Rodríguez-Barbero A
Cell Physiol Biochem; 2004; 14(4-6):301-10. PubMed ID: 15319534
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
14. Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures.
Flynn RS; Mahavadi S; Murthy KS; Grider JR; Kellum JM; Akbari H; Kuemmerle JF
Inflamm Bowel Dis; 2011 Jan; 17(1):193-201. PubMed ID: 20848532
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.
Beddy D; Mulsow J; Watson RW; Fitzpatrick JM; O'Connell PR
Br J Surg; 2006 Oct; 93(10):1290-6. PubMed ID: 16838391
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.
Meurer SK; Tihaa L; Borkham-Kamphorst E; Weiskirchen R
Cell Signal; 2011 Apr; 23(4):683-99. PubMed ID: 21146604
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.
Li C; Iness A; Yoon J; Grider JR; Murthy KS; Kellum JM; Kuemmerle JF
J Immunol; 2015 Apr; 194(7):3422-31. PubMed ID: 25740948
[TBL] [Abstract][Full Text] [Related]
18. Fetal and adult fibroblasts have similar TGF-beta-mediated, Smad-dependent signaling pathways.
Colwell AS; Krummel TM; Longaker MT; Lorenz HP
Plast Reconstr Surg; 2006 Jun; 117(7):2277-83. PubMed ID: 16772929
[TBL] [Abstract][Full Text] [Related]
19. Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation.
Noskovičová N; Heinzelmann K; Burgstaller G; Behr J; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L695-L707. PubMed ID: 29351434
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease.
Burke JP; Ferrante M; Dejaegher K; Watson RW; Docherty NG; De Hertogh G; Vermeire S; Rutgeerts P; D'Hoore A; Penninckx F; Geboes K; Van Assche G; O'Connell PR
Inflamm Bowel Dis; 2008 Sep; 14(9):1197-204. PubMed ID: 18452219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
